Viewing Study NCT00003895


Ignite Creation Date: 2025-12-24 @ 1:30 PM
Ignite Modification Date: 2026-05-26 @ 1:25 PM
Study NCT ID: NCT00003895
Status: COMPLETED
Last Update Posted: 2017-02-20
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Melanoma View
None Stage IA Melanoma View
None Stage IB Melanoma View
None Stage IIA Melanoma View
None Stage IIB Melanoma View
None Stage IIC Melanoma View
None Stage IIIA Melanoma View
None Stage IIIB Melanoma View
None Stage IIIC Melanoma View
Keywords: